Ferabright Injection
Product Images NDC 24338-310

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ferabright (NDC 24338-310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Azurity Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-10ml-carton (Spl 10ml Carton)

This text is a detailed description of Ferabright, a pharmaceutical product. It is an injection containing ferumoxytol, providing 300 mg elemental iron per 10 mL after proper dilution. The injection should be used intravenously after dilution with specific solutions such as Sodium Chloride or Dextrose Injections. The dosage recommendation can be found in the Prescribing Information. The product should be stored at a temperature range of 20° to 25°C (68° to 77°F) with excursions allowed between 15° to 30°C (59° to 86°F). The text repeats information about its composition, dosage, and administration for clarity.*

FDA Label Image

Spl-10ml-label (Spl 10ml Label)

This is a description of Ferabright™, a single-dose vial of ferumoxytol injection containing 300 mg of elemental iron per 10 mL. It is recommended for intravenous use after dilution only and is formulated with polyglucose sorbitol carboxymethylether iron oxide and mannitol. The text provides information on dosage, storage conditions, and manufacturer details.*

FDA Label Image

Spl-17ml-carton (Spl 17ml Carton)

This text contains information on Ferabright™ (ferumoxytol injection) which is a medication used intravenously after dilution. It provides details on the dosage, elements present in each mL, dilution requirements, and storage conditions. The product contains 510 mg elemental iron per 17 mL and should be diluted in either 0.9% Sodium Chloride Injection or Dextrose Injection. Additionally, the text mentions that each vial is for single-dose use and any unused portion should be discarded. For more specific information, the text suggests referring to the prescribing information.*

FDA Label Image

Spl-17ml-label (Spl 17ml Label)

This text provides details about a pharmaceutical product called Ferabright™, which is a ferumoxytol injection containing 510 mg of elemental iron per 17 mL. It is intended for intravenous use after dilution and comes in a single-dose vial. The formulation includes iron oxide and polyglucose sorbitol carboxymethylether, with mannitol as an additional component. The recommended dosage should be followed as per the Prescribing Information provided. It also includes instructions for storage between 20°C to 25°C, with excursions permitted to 15°C to 30°C, and the caution not to freeze the product.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.